There haven't been many positive catalysts for MannKind Corporation (NASDAQ: MNKD) in a few months. The stock is down significantly so far in 2018 after starting off with some nice gains. But there was at least a chance for some good news when the company reported its first-quarter results after the market closed on Wednesday.As it turned out, the biotech did have some good news.